Midocalm, pills 150mg, 30pcs

Composition

1 tablet contains:

Active ingredients:

Tolperisone hydrochloride 150 mg,

Auxiliary substances:

lactose,

citric acid monohydrate,

colloidal anhydrous silicon,

stearin,

talc,

microcrystalline cellulose,

corn starch,

titanium dioxide (E 171),

dye (E 129 or E 172).

Film shell:

colloidal silicon dioxide;

titanium dioxide (E 171-77891);

lactose monohydrate;

macrogol 6000;

hypromellose

Pharmacological action

Mydocalm is a central-acting muscle relaxant.

Reduces pathologically increased muscle tone, muscle rigidity, improves voluntary active movements.

The mechanism of action is associated with a regulatory effect on the caudal part of the reticular formation, suppression of pathologically increased spinal reflex activity, and effects on peripheral nerve endings.

Indications

• treatment of pathologically increased muscle tone and spasms of striated muscle, arising from organic diseases of the Central nervous system (loss of pyramidal pathways, multiple sclerosis, cerebral stroke, myelopathy, encephalomyelitis);
• treatment increased tone and spasticity, muscle contractures, accompanying diseases of the organs of motion (including spondylosis, spondylosis, cervical and lumbar syndromes, arthritis of large joints);
• medical rehabilitation after orthopaedic and trauma surgeries;
• in a combination therapy of occlusive vascular diseases (atherosclerosis, diabetic angiopathy, thromboangiitis obliterans, Raynaud’s disease, diffuse scleroderma), diseases resulting from disorders of innervation of the vessels (acrocyanosis, intermittent angioneurotic dysbasia);
• little’s disease (infantile cerebral paralysis) and other encephalopathy accompanied by muscle dystonia.

Use during pregnancy and lactation

Medication Mydocalm is contraindicated during pregnancy, breast-feeding and children under 3 years of age.

Contraindications

• hypersensitivity to any of the components of the drug;
• myasthenia gravis.

Side effects

• drowsiness,
• nausea,
• dizziness
• dry mouth,
• constipation,
• diarrhea,
• decreased blood pressure
• feeling tired,
• sleep disorders,
• confusion.

Interaction

Data on interactions that limit the use of the drug Midocalm, not available.

Although Tolperisone has an effect on the central nervous system, it does not cause sedation, so it can be used in combination with sedatives, sleeping pills and drugs containing alcohol.

It does not affect the effect of alcohol on the central nervous system.

Tolperisone enhances the effect of niflumic acid, with the simultaneous use of these drugs, it may be necessary to reduce the dose of niflumic acid.

General anaesthetics, peripheral muscle relaxants, psychotropic drugs, and clonidine enhance the effect of Tolperisone.

How to take, course of use and dosage

In most cases, adults are prescribed 150 mg 3 times a day.

Children aged 1 to 6 years of age are prescribed Mydocalm orally at a daily dose of 5-10 mg/kg (in 3 doses during the day);

at the age of 7-14 years-at a daily dose of 2-4 mg / kg in 3 doses.

Overdose

Data on drug overdose No midocalms were received.

Special instructions

Use strictly as prescribed by your doctor to avoid complications.

Influence on the ability to drive vehicles and mechanisms.

Studies have not been conducted, but for many years of practice using the drug, such information has not been received.

Form of production

Pills.

Storage conditions

In a dry place, at a temperature of 15-30 °C

Shelf life

3 years

Active ingredient

Tolperisone

Conditions of release from pharmacies

By prescription

Dosage form

Tablets

Description

Children as prescribed by a doctor, Adults as prescribed by a doctor, Children over 3 years of age

Indications

Muscle Spasm, Osteochondrosis, Osteoarthritis, Lumbago, Sciatica, Osteoarthritis, Stroke Effects, Arthritis, Sciatica